Fast-Track Strategy to End AIDS Epidemic Financially Sound

December 21, 2018

The international Fast-Track strategy to end the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic worldwide by 2030 makes solid financial sense, according to a study published online in Health Policy.

Agreed on in 2016, the ambitious strategy aims to markedly reduce new HIV infections, AIDS-related deaths, and HIV-related discrimination. Researchers assessed the economic returns likely to result from the project.

Between 2017 and 2030, incremental costs of the Fast-Track scenario were estimated at $86 billion, or $13.69 per capita, researchers reported. A full-income analysis, which valued both changes in income and mortality, showed that incremental benefits of the decrease in mortality would amount to $88.14 per capita, or 6.44 times the resources invested for all countries.

“In all regions, the economic and social value of the additional life-years saved by the Fast-Track approach exceeds its incremental costs,” researchers wrote, “implying that this strategy for ending the AIDS epidemic is a sound economic investment.”

While the return on investment differs by region, the Asia-Pacific region and Eastern and Southern Africa are on tap to realize the largest returns, according to the study.

Jolynn Tumolo


Lamontagne E, Over M, Stover J. The economic returns of ending the AIDS epidemic as a public health threat. Health Policy. 2018 November 22;[Epub ahead of print].

For articles by First Report Managed Care, click here

To view the First Report Managed Care print issue, click here